Taken together, it is speculated that RB1CC1 may act as an oncogene in large intestine, and that 3′UTR MSI may serve as an upregulatory mechanism in place of genomic amplification in MSI-H cancers that typically lack chromosomal aberrations. Here, RB1CC1 is linked to cancer.